VLA
Click for more information
0.00% $1.75 viralytics limited

positive results for viralytics cavatak trial

  1. skhammer
    925 Posts.
    clock Created with Sketch.
    09/04/13
    09:34
    Post #: 11619412
    Great news to see mild efficacy from a single dose of CAVATAK intravenously but the best part of this announcement is that the second Phase II trial will incorporate the combination treatment of CAVATAK and a chemo drug. I always hoped this would happen as it broadens the use of CAVATAK tremendously.

    Looking forward to the markets reactions, although not expecting an NRT reaction by any means
    VLA Price at posting: 31.3¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.